What's New in DED in 2026?

• January 1, 2026

Dry Eye Dx and Tx: Malfunctioning Mucins

Exploring the underappreciated role of mucins in dry eye disease reveals promising therapeutic avenues for improved management.

• by Roxanna Potter, OD

• January 1, 2026

• 4 min

A Conversation With Liz Risenberg of Lumenis

Industry Insider
Liz Risenberg discusses the launch of the OptiLIFT device, the benefits it provides to ophthalmology practices, and what inspires her the most about the work the company does.

• by Julie Greenbaum, editor

• January 1, 2026

• 4 min

A Vision for Growth

Capital, innovation, and the next wave of ophthalmic breakthroughs

• by Jeanne Taylor Hecht , David J. Tanzer

• February 2, 2026

• 7 min